Voyager Therapeutics (VYGR) Capital Expenditures Growth (1y) (2015 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Capital Expenditures Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 87.24% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | -27.07% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 18.48% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -98.25% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | -78.75% |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | -81.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -81.90% |
| Mar 31, 2026 | -97.87% |
| Dec 31, 2025 | 303.87% |
| Sep 30, 2025 | -19.77% |
| Jun 30, 2025 | 14.27% |
| Mar 31, 2025 | -69.27% |
| Dec 31, 2024 | -79.47% |
| Sep 30, 2024 | -67.01% |
| Jun 30, 2024 | -20.08% |
| Mar 31, 2024 | 320.63% |
| Dec 31, 2023 | -19.08% |
| Sep 30, 2023 | 181.29% |
| Jun 30, 2023 | 15.02% |
| Mar 31, 2023 | 123.25% |
| Dec 31, 2022 | 168.88% |
| Sep 30, 2022 | -57.88% |
| Jun 30, 2022 | 363.44% |
| Mar 31, 2022 | -39.20% |
| Dec 31, 2021 | -90.24% |
| Sep 30, 2021 | -87.19% |